The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-Benzyloxyphenylmethyl)-5-trifluoromethyl-1Hpyrazol-3-ylbeta-D-glucopyranoside ID: ALA2159094
Chembl Id: CHEMBL2159094
PubChem CID: 10301121
Max Phase: Preclinical
Molecular Formula: C24H25F3N2O7
Molecular Weight: 510.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: OC[C@H]1O[C@@H](Oc2n[nH]c(C(F)(F)F)c2Cc2ccccc2OCc2ccccc2)[C@H](O)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C24H25F3N2O7/c25-24(26,27)21-15(10-14-8-4-5-9-16(14)34-12-13-6-2-1-3-7-13)22(29-28-21)36-23-20(33)19(32)18(31)17(11-30)35-23/h1-9,17-20,23,30-33H,10-12H2,(H,28,29)/t17-,18-,19+,20-,23+/m1/s1
Standard InChI Key: VRWBPJPUNCXWHA-MZSWFSNMSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 510.47Molecular Weight (Monoisotopic): 510.1614AlogP: 1.78#Rotatable Bonds: 8Polar Surface Area: 137.29Molecular Species: NEUTRALHBA: 8HBD: 5#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.13CX Basic pKa: 0.76CX LogP: 2.76CX LogD: 2.76Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.31Np Likeness Score: 0.40
References 1. Fushimi N, Fujikura H, Shiohara H, Teranishi H, Shimizu K, Yonekubo S, Ohno K, Miyagi T, Itoh F, Shibazaki T, Tomae M, Ishikawa-Takemura Y, Nakabayashi T, Kamada N, Ozawa T, Kobayashi S, Isaji M.. (2012) Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia., 20 (22): [PMID:23062824 ] [10.1016/j.bmc.2012.09.037 ]